Status:
COMPLETED
Endovascular treatmenT for Acute Ischemic Stroke in China
Lead Sponsor:
General Hospital of Shenyang Military Region
Conditions:
Stroke
Endovascular Treatment
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.
Eligibility Criteria
Inclusion
- Age: ≥ 18;
- Ischemic stroke confirmed by head CT or MRI;
- Patients receiving endovascular treatment;
- First ever stroke or mRS≤2 after previous disease;
- Complete and clear pre- and post-operative DSA images are available
Exclusion
- Imaging data not qualified for evaluation;
- Absence of important clinical data;
- The first 50 patients receiving endovascular treatment in a single centerr.
Key Trial Info
Start Date :
March 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 8 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04752735
Start Date
March 22 2021
End Date
February 8 2023
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China, 110016